BSAC Spring Conference

Reigniting the AMR agenda

THIS CONFERENCE IS CPD ACCREDITED

HELD 10-11 MAY 2022

BSAC Spring Conference 2022
Reigniting the AMR Agenda

10-11 May 2022

Please find below links to the presentation from the 2022 BSAC Spring Conference

Day 1

SESSION ONE: THE IMPORTANCE OF DATA AND COMMUNICATION

This video consists of the following presentations:

The vital role of data in pandemic preparedness and management

Dr Susan Hopkins, Consultant, PHE/ DHSC / Royal Free Hospital

Data-driven communication to raise awareness of AMR and drive rational use of antibiotics

Dr Alex Costa, Health Programme Team, UNICEF

Q&A

SESSION TWO: ROUTINE OR RAPID - HOW DO WE GET IT RIGHT?

This video consists of the following presentations:

Was the Longitude Prize too early? Are we ready for rapid diagnostics?

Mr Daniel Berman, Director, Global Health, Nesta Challenges

The blood culture pathway - how can we get it right?

Dr Michael Weinbren, AMR Diagnostics Programme Clinical Lead, NHS England and NHS Improvement

The effectiveness of rapid diagnostic tests for antimicrobial resistance

Dr Rebecca Glover, Assistant Professor in Health Policy, LSHTM

Q&A

All speakers, plus panellist Dr Rosemary Stevenson, AMR Diagnostics Programme Lead (Science & Policy Lead), NHS England and NHS Improvement

SESSION SIX: VACCINES - WHAT NOW? WHAT NEXT?

This video consists of the following presentations:

Lessons learnt from COVID vaccine development 

Dr Charlie Weller, Head of Prevention, Infectious Diseases, Wellcome

Pneumococcal vaccine – a success story in progress

Professor Keith Klugman, Director, Bill & Melinda Gates Foundation

Q&A

SESSION SEVEN: Keynote Lecture

This video consists of the following presentations:

The GRAM report - implications for infection management

Dr Christopher J.L. Murray, Chair of Health Metrics Sciences, University of Washington & Director of the Institute for Health Metrics and Evaluation (IHME).

SESSION EIGHT: The physician, the pharmacist, the nurse and their microbiologist - the pivotal role of a MDT approach to behavioural science

This video consists of the following presentations:

Interactive panel presentations and discussion on the successes and failures of behavioural science interventions

Dr Esmita Charani, Senior Lead Pharmacist, Imperial College London, Professor Carolyn Tarrant, Professor of Health Services Research, University of Leicester, Dr Eva Krockow, Lecturer in Psychology, University of Leicester, Ms Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital

Panel discussion

Day 2

SESSION NINE: CLINICAL LESSONS

This video consists of the following presentations:

Nuances of implementing antibiotic stewardship in high prescribing English general practices: an implementation study

Dr Sarah Tonkin-Crine, Associate Professor and Health Psychologist, University of Oxford

TRAIL, IP-10, CRP Host-protein Signature score distinguishes between Viral and Bacterial Infection in Sepsis Patients

Dr Jeroen Stas, Medical Affairs Manager, MeMed Diagnostics

ST97 Staphylococcus aureus and oxacillin resistance: An emerging challenge for microbiologists?

Gareth Hughes, ST7 Microbiology & Infectious diseases, UKHSA Lab

Q&A

SESSION TEN: INFECTION CONUNDRUMS

This video consists of the following presentations:

Approaches to Complex Urinary Tract Infections

Dr Annie Joseph, Consultant Microbiologist, Nottingham University Hospitals NHS Trust, Dr Tom Lewis, Northern Devon NHS Healthcare Trust

Intra-abdominal infections

Professor Mark Wilcox, Consultant / Head of Microbiology Research & Development / and Infection Lead of the Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative, Leeds Teaching Hospitals NHS Trust

Management of penicillin allergy labels

Dr Jonathan Sandoe, Associate Professor, University of Leeds, Leeds Teaching Hospitals NHS Trust

Recent trends in serious fungal infection incidence, mortality and antifungal resistance

Professor David Denning, Professor of Infectious Diseases in Global Health, The University of Manchester

Q&A

SESSION TWELVE: EQUITABLE ACCESS

This video consists of the following presentations:

Accelerating appropriate access to new antibiotics: Cefiderocol as a pathfinder

Jennifer Cohn, Global Access Project Leader, Global Antibiotic Research and Development Partnership (GARDP)

Laboratory capacity for all - developing mobile laboratory services

Dr Alessandra Natale, Research Coordinator, Médecins Sans Frontières

Q&A

SESSION FOURTEEN: ACCREDITATION AND COLLABORATION - THE BEST WAY FORWARD!

This video consists of the following presentations:

Supporting shared learning and stakeholder collaboration via the Global Antimicrobial Stewardship hub (GASP-h)

Professor Dilip Nathwani

Developing a UK Antimicrobial Registry – a BSAC collaboration with academic and industry partners

Dr Jacqueline Sneddon, Programmes Manager, BSAC

Launch of the Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) – supporting a quality improvement approach

Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust

Civil-private sector-public alliance: AMR, COVID-19, and the Investment Community

Professor Dilip Nathwani, Dr Claudie Charbonneau, Pfizer

Panel discussion & Q&A

SESSION FIFTEEN: ANTIMICROBIAL SUSCEPTIBILITY TESTING

This video consists of the following presentations:

Interpreting EUCAST recommendations

Pegah Hafezi, AST LEAD, Severn Pathology, Bristol

Implementing RAST in routine microbiology services

Dr Per Rydstrom, Consultant clinical microbiologist, Clinical microbiology for Kronoberg and Blekinge County, Sweden

Whole genome sequencing as a tool for prediction of antimicrobial resistance: pros & cons

Dr Massimo Mentasti, Senior Scientist, Public Health Wales NHS Trust

Q&A

Poster abstracts

Top